Top

Published in:

01-07-2016 | Original Scientific Report

Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1

Authors: Caroline L. Lopez, Max B. Albers, Carmen Bollmann, Jerena Manoharan, Jens Waldmann, Volker Fendrich, Detlef K. Bartsch

Published in: World Journal of Surgery | Issue 7/2016

Abstract

Objective

The role of minimally invasive pancreatic surgery for pancreatic neuroendocrine neoplasms (pNENs) in patients with multiple endocrine neoplasia type 1 (MEN1) is not well defined. The aim of this study was to compare the outcome of minimally invasive versus open pancreatic resections in patients with MEN1.

Materials and methods

Prospectively collected data of MEN1 patients who underwent a primary distal pancreatic resection and/or enucleation for non-functioning pNENs or insulinoma were retrospectively analyzed regarding the outcome of minimally invasive or open pancreatic resections.

Results

Thirty-three patients underwent primary pancreatic resection for either organic hyperinsulinism (n = 9, 27 %) or non-functioning pNENs >1 cm in size (n = 24, 73 %) between 1987 and 2015. 21 (64 %) patients underwent an open surgical (group 1) and 12 patients (36 %) a minimally invasive approach, either laparoscopic (n = 8) or robotic assisted (n = 4) (group 2). Both groups were comparable regarding age, gender, number, and size of pancreatic tumors. In both groups, the hyperinsulinism of all patients (9/9,100 %) could be cured and all NF-pNENs >1 cm could be resected. Group 2 had a significant shorter operative time (200 vs. 260 min; p = 0.036), less intraoperative blood loss (120 vs. 280 ml; p < 0.001), and a shorter hospital stay (11 vs. 15.5 days; p = 0.034). The rate of patients with postoperative complications, especially postoperative pancreatic fistulas, was not different between groups (62 % group 1 vs. 67 % group 2, p = 0.74).

Conclusion

Minimally invasive distal pancreatic resections and enucleations are feasible and safe in MEN1 patients with insulinoma or non-functioning pNENs.

Brandi ML (2000) Multiple endocrine neoplasia type 1. Rev Endocr Metab Disord 1:275–282CrossRefPubMed

Trump D, Farren B, Wooding C et al (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM 89:653–669CrossRefPubMed

Marx S, Spiegel AM, Skarulis MC, Doppmann JL, Collins FS, Liotta LA (1998) Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129:484–494CrossRefPubMed

Carney JA (2005) Familial multiple endocrine neoplasia: the first 100 years. Am J Surg Pathol 29:254–274 Review CrossRefPubMed

Chandrasekharappa SC, Guru SC, Manickam P et al (1997) Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 276:404CrossRefPubMed

Waldmann J, Fendrich V, Habbe N et al (2009) Screening of patients with endocrine neoplasia type 1 (MEN-1): a critical analysis of its value. World J Surg 33:1208–1218. doi:10.1007/s00268-009-9983-8 CrossRefPubMed

Thomas-Marquez L, Murat A, Delemer B et al (2006) Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1. Am J Gastroenterol 101:266–273CrossRef

Schussheim DH, Skarulis MC, Agarwal SK et al (2001) Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocrinol Metab 12:173–178CrossRefPubMed

Carty SE, Helm AK, Amico JA et al (1998) The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery 124:1106–1111CrossRefPubMed

10.

Triponez F, Dosseh D, Goudet P et al (2006) Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas. Ann Surg 243(2):265–272CrossRefPubMedPubMedCentral

11.

Goudet P, Murat A, Binquet C et al (2010) Risk factors and causes of death in MEN1 disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg 34:249–255. doi:10.1007/s00268-009-0290-1 CrossRefPubMed

12.

Thakker RV, Newey PJ, Walls GV et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97(9):2990–3011CrossRefPubMed

13.

Falconi M, Bartsch DK, Eriksson B et al (2012) ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology 95(2):120–134CrossRefPubMed

14.

Kulke MH, Anthony LB, Bushnell DL et al (2010) NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas; North American Neuroendocrine Tumor Society (NANETS). Pancreas 39(6):735–752CrossRefPubMedPubMedCentral

15.

Cuschieri A, Jakimowicz JJ, van Spreeuwel J (1996) Laparoscopic distal 70 % pancreatectomy and splenectomy for chronic pancreatitis. Ann Surg 223:280–285CrossRefPubMedPubMedCentral

16.

Merchant NB, Parikh AA, Kooby DA (2009) Should all distal pancreatectomies be performed laparoscopically? Adv Surg 43:283–300CrossRefPubMed

17.

Briggs CD, Mann CD, Irving GR et al (2009) Systematic review of minimally invasive pancreatic resection. J Gastrointest Surg 13:1129–1137CrossRefPubMed

18.

Nigri GR, Rosman AS, Pertrucciani N et al (2011) Meta-analysis of trials comparing minimally invasive and open distal pancreatectomies. Surg Endosc 25:1642–1651CrossRefPubMed

19.

Drymousis P, Raptis DA, Spalding D et al (2014) Laparoscopic versus open pancreas resection for pancreatic neuroendocrine tumours: a systematic review and meta-analysis. HPB (Oxford) 16(5):397–406 Review CrossRef

20.

Bartsch DK, Slater EP, Albers MB et al (2014) Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain. J Clin Endocrinol Metab 99(11):E2387–E2391CrossRefPubMed

21.

Lopez CL, Waldmann J, Fendrich V et al (2011) Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1. Langenbecks Arch Surg 396(8):1187–1196CrossRefPubMed

22.

Kimura W, Yano M, Suqawara S, Okazaki S et al (2010) Spleen-preserving distal pancreatectomy with conservation of the splenic artery and vein: techniques and its significance. J Hepatobiliary Pancreat Sci 17(6):813–823CrossRefPubMed

23.

Warshaw AL (2010) Distal pancreatectomy with preservation of the spleen. J Hepatobiliary Pancreat Sci 17(6):808–812 Review CrossRefPubMed

24.

Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138(1):8–13CrossRefPubMed

25.

Klöppel G, Perren A, Heitz PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014:13–27 Review CrossRefPubMed

26.

de Rooij T, Jilesen AP, Boerma D, Dutch Pancreatic Cancer Group et al (2015) A nationwide comparison of laparoscopic and open distal pancreatectomy for benign and malignant disease. J Am Coll Surg 220(3):263–270CrossRefPubMed

27.

Inchauste SM, Lanier BJ, Libutti SK et al (2012) Rate of clinically significant postoperative pancreatic fistula in pancreatic neuroendocrine tumors. World J Surg 36(7):1517–1526. doi:10.1007/s00268-012-1598-9 CrossRefPubMedPubMedCentral

28.

Davì MV, Boninsegna L, Dalle Carbonare L et al (2011) Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome. Neuroendocrinology 94(1):58–65CrossRefPubMed

29.

Damoli I, Butturini G, Ramera M et al (2015) Minimally invasive pancreatic surgery—a review. Wideochir Inne Tech Maloinwazyjne 10(2):141–149PubMedPubMedCentral

30.

Stafford AT, Walsh RM (2015) Robotic surgery of the pancreas: the current state of the art. J Surg Oncol. doi:10.1002/jso.23952 PubMed

31.

Dʼsouza SL, Elmunzer BJ, Scheiman JM (2014) Long-term follow-up of asymptomatic pancreatic neuroendocrine tumors in multiple endocrine neoplasia type I syndrome. J Clin Gastroenterol 48(5):458–461PubMed

Title: Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1
Authors: Caroline L. Lopez
Max B. Albers
Carmen Bollmann
Jerena Manoharan
Jens Waldmann
Volker Fendrich
Detlef K. Bartsch
Publication date: 01-07-2016
Publisher: Springer International Publishing
Published in: World Journal of Surgery / Issue 7/2016
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-016-3456-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1

Abstract

Objective

Materials and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2016

The Case for Oxygen in Global Surgical Care

Managing Soft Tissue Sarcomas in a Developing Health System

Effects of Minimally Invasive Esophagectomy and Open Esophagectomy on Circulating Tumor Cell Level in Elderly Patients with Esophageal Cancer

Clinicopathological Characteristics and Prognostic Factors of Patients with Siewert Type II Esophagogastric Junction Carcinoma: A Retrospective Multicenter Study

Isolated Resection of Segment VIII: A Technique for Drainage Through the Couinaud Space to Prevent Postoperative Collections

The Role of Planned and On-Demand Relaparotomy in the Developing World